Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: memo - Magazine of European Medical Oncology 2/2014

01.05.2014 | short review

Follow-up in gastrointestinal cancer

verfasst von: Ulrich Popper, Clemens Dormann, MD Holger Rumpold

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten
share
TEILEN

Abstract

Follow-up after curative treatment of patients with gastrointestinal cancers aims to detect recurrent disease and to provide curative treatment to prolong overall survival if possible. This, however, has only been shown for colorectal cancers. Regular visits including testing of carcinoembryonic antigen and appropriate staging has been shown to enable curative treatment even in relapse. For other gastrointestinal cancers, positive effects of regular follow-up visits on survival have not been shown so far. This is mostly also due to lacking curative treatment strategies in case of relapse. In these cases, follow-up is recommended for providing palliative treatment, detecting recurrence for quality issues, treating complications or symptoms due to relapse, and providing psychological support. This review will give a brief overview about the current follow-up issues in colorectal, esophagogastric, and pancreatic cancers, as these are clinically the most relevant.
Literatur
2.
Zurück zum Zitat Enbald P, Adami HA, Glimelius B, et al. The risk of subsequent primary malignant diseases after cancers of the colon and rectum. A nationwide cohort study. Cancer. 1990;65(9):2091–100. CrossRef Enbald P, Adami HA, Glimelius B, et al. The risk of subsequent primary malignant diseases after cancers of the colon and rectum. A nationwide cohort study. Cancer. 1990;65(9):2091–100. CrossRef
3.
Zurück zum Zitat Cali RL, Pitsch RM, Thorson AG, et al. Cumulative incidence of metachronous colorectal cancer. Dis Colon Rectum. 1993;36(4):388–93. PubMedCrossRef Cali RL, Pitsch RM, Thorson AG, et al. Cumulative incidence of metachronous colorectal cancer. Dis Colon Rectum. 1993;36(4):388–93. PubMedCrossRef
4.
Zurück zum Zitat Hermanek P, Jr., Wiebelt H, Riedl S, Staimmer D, Hermanek P. Long-term results of surgical therapy of colon cancer. Results of the colorectal cancer study group. Chirurg. 1994;65:287–97. PubMed Hermanek P, Jr., Wiebelt H, Riedl S, Staimmer D, Hermanek P. Long-term results of surgical therapy of colon cancer. Results of the colorectal cancer study group. Chirurg. 1994;65:287–97. PubMed
5.
Zurück zum Zitat Yamazaki T, Takii Y, Okamoto H, Sakai Y, Hatakeyama K. What is the risk factor for metachronous colorectal carcinoma? Dis Colon Rectum. 1997;40(8):935–8. PubMedCrossRef Yamazaki T, Takii Y, Okamoto H, Sakai Y, Hatakeyama K. What is the risk factor for metachronous colorectal carcinoma? Dis Colon Rectum. 1997;40(8):935–8. PubMedCrossRef
6.
Zurück zum Zitat Hemminki K, Li X, Dong C. Second primary cancers after sporadic and familial colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2001;10(7):793–8. PubMed Hemminki K, Li X, Dong C. Second primary cancers after sporadic and familial colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2001;10(7):793–8. PubMed
7.
Zurück zum Zitat Pietra N, Sarli L, Thenasseril BJ, Costi R, Sansebastiano G, Peracchia A. Risk factors of local recurrence of colorectal cancer: a multivariate study. Hepatogastroenterology. 1998;45(23):1573–8. PubMed Pietra N, Sarli L, Thenasseril BJ, Costi R, Sansebastiano G, Peracchia A. Risk factors of local recurrence of colorectal cancer: a multivariate study. Hepatogastroenterology. 1998;45(23):1573–8. PubMed
8.
Zurück zum Zitat Yamamoto S, Akasu T, Fujita S, Moriya Yamamoto S, Akasu T, Fujita S, Moriya Y. Postsurgical surveillance for recurrence of UICC stage I colorectal carcinoma: is follow-up by CEA justified? Hepatogastroenterology. 2005;52(62):444–9. PubMed Yamamoto S, Akasu T, Fujita S, Moriya Yamamoto S, Akasu T, Fujita S, Moriya Y. Postsurgical surveillance for recurrence of UICC stage I colorectal carcinoma: is follow-up by CEA justified? Hepatogastroenterology. 2005;52(62):444–9. PubMed
9.
Zurück zum Zitat Colibaseanu DT, Mathis KL, Abdelsattar ZM, Larson DW, Haddock MG, Dozois EJ. Is curative resection and long-term survival possible for locally re-recurrent colorectal cancer in the pelvis? Dis Colon Rectum. 2013;56(1):14–9. PubMedCrossRef Colibaseanu DT, Mathis KL, Abdelsattar ZM, Larson DW, Haddock MG, Dozois EJ. Is curative resection and long-term survival possible for locally re-recurrent colorectal cancer in the pelvis? Dis Colon Rectum. 2013;56(1):14–9. PubMedCrossRef
10.
Zurück zum Zitat Kanas GP, Taylor A, Primrose JN, et al. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol. 2012;4:283–301. PubMedCentralPubMed Kanas GP, Taylor A, Primrose JN, et al. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol. 2012;4:283–301. PubMedCentralPubMed
11.
Zurück zum Zitat Gonzalez M, Poncet A, Combescure C, Robert J, Ris HB, Gervaz P. Risk factors for survival after lung metastasectomy in colorectal cancer patients: a systematic review and meta-analysis. Ann Surg Oncol. 2013;20(2):572–9. PubMedCrossRef Gonzalez M, Poncet A, Combescure C, Robert J, Ris HB, Gervaz P. Risk factors for survival after lung metastasectomy in colorectal cancer patients: a systematic review and meta-analysis. Ann Surg Oncol. 2013;20(2):572–9. PubMedCrossRef
12.
Zurück zum Zitat Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. J Clin Oncol. 1992;10(6):904–11. Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. J Clin Oncol. 1992;10(6):904–11.
13.
Zurück zum Zitat Yamamoto S, Akasu T, Fujita S, et al. Postsurgical surveillance for recurrence of UICC stage I colorectal carcinoma: is follow-up by CEA justified? Hepatogastroenterology. 2005;52(62):444–9. PubMed Yamamoto S, Akasu T, Fujita S, et al. Postsurgical surveillance for recurrence of UICC stage I colorectal carcinoma: is follow-up by CEA justified? Hepatogastroenterology. 2005;52(62):444–9. PubMed
14.
Zurück zum Zitat Körner H, Søreide K, Stokkeland PJ, et al. Systematic follow-up after curative surgery for colorectal cancer in Norway: a population-based audit of effectiveness, costs, and compliance. J Gastrointest Surg. 2005;9(3):320–8. PubMedCrossRef Körner H, Søreide K, Stokkeland PJ, et al. Systematic follow-up after curative surgery for colorectal cancer in Norway: a population-based audit of effectiveness, costs, and compliance. J Gastrointest Surg. 2005;9(3):320–8. PubMedCrossRef
15.
Zurück zum Zitat Talbot IC, Ritchie S, Leighton MH, et al. The clinical significance of invasion of veins by rectal cancer. Br J Surg. 1980;67(6):439–42. PubMedCrossRef Talbot IC, Ritchie S, Leighton MH, et al. The clinical significance of invasion of veins by rectal cancer. Br J Surg. 1980;67(6):439–42. PubMedCrossRef
16.
Zurück zum Zitat Minsky BD, Mies C, Recht A, et al. Resectable adenocarcinoma of the rectosigmoid and rectum. II. The influence of blood vessel invasion. Cancer. 1988;61(7):1417–24. PubMedCrossRef Minsky BD, Mies C, Recht A, et al. Resectable adenocarcinoma of the rectosigmoid and rectum. II. The influence of blood vessel invasion. Cancer. 1988;61(7):1417–24. PubMedCrossRef
17.
Zurück zum Zitat Krasna MJ, Flancbaum L, Cody RP, Shneibaum S, Ari GB. Vascular and neural invasion in colorectal carcinoma. Incidence and prognostic significance. Cancer. 1988;61(5):1018–23. PubMedCrossRef Krasna MJ, Flancbaum L, Cody RP, Shneibaum S, Ari GB. Vascular and neural invasion in colorectal carcinoma. Incidence and prognostic significance. Cancer. 1988;61(5):1018–23. PubMedCrossRef
18.
Zurück zum Zitat Inoue T, Mori M, Shimono R, et al. Vascular invasion of colorectal carcinoma readily visible with certain stains. Dis Colon Rectum. 1992;35(1):34–9. PubMedCrossRef Inoue T, Mori M, Shimono R, et al. Vascular invasion of colorectal carcinoma readily visible with certain stains. Dis Colon Rectum. 1992;35(1):34–9. PubMedCrossRef
19.
Zurück zum Zitat Green RJ, Metlay JP, Propert K, et al. Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089. Ann Intern Med. 2002;136(4):261–9. PubMedCrossRef Green RJ, Metlay JP, Propert K, et al. Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089. Ann Intern Med. 2002;136(4):261–9. PubMedCrossRef
20.
Zurück zum Zitat Harris GJ, Church JM, Senagore AJ, et al. Factors affecting local recurrence of colonic adenocarcinoma. Dis Colon Rectum. 2002;45(8):1029–34. PubMedCrossRef Harris GJ, Church JM, Senagore AJ, et al. Factors affecting local recurrence of colonic adenocarcinoma. Dis Colon Rectum. 2002;45(8):1029–34. PubMedCrossRef
21.
Zurück zum Zitat Merkel S, Meyer T, Gohl J, Hohenberger W. Late locoregional recurrence in rectal carcinoma. Eur J Surg Oncol. 2002;28(7):716–22. PubMedCrossRef Merkel S, Meyer T, Gohl J, Hohenberger W. Late locoregional recurrence in rectal carcinoma. Eur J Surg Oncol. 2002;28(7):716–22. PubMedCrossRef
22.
Zurück zum Zitat Poulin EC, Schlachta CM, Gregoire R, et al. Local recurrence and survival after laparoscopic mesorectal resection forrectal adenocarcinoma. Surg Endosc. 2002;16(6):989–95. PubMedCrossRef Poulin EC, Schlachta CM, Gregoire R, et al. Local recurrence and survival after laparoscopic mesorectal resection forrectal adenocarcinoma. Surg Endosc. 2002;16(6):989–95. PubMedCrossRef
23.
Zurück zum Zitat Bulow S, Christensen IJ, Harling H, et al. Recurrence and survival after mesorectal excision for rectal cancer. Br J Surg. 2003;90(8):974–80. PubMedCrossRef Bulow S, Christensen IJ, Harling H, et al. Recurrence and survival after mesorectal excision for rectal cancer. Br J Surg. 2003;90(8):974–80. PubMedCrossRef
24.
Zurück zum Zitat Schoemaker D, Black R, Giles L, Toouli J. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology. 1998;114(1):7–14. PubMedCrossRef Schoemaker D, Black R, Giles L, Toouli J. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology. 1998;114(1):7–14. PubMedCrossRef
25.
Zurück zum Zitat Secco GB, Fardelli R, Gianquinto D, et al. Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol. 2002;28(4):418–23. PubMedCrossRef Secco GB, Fardelli R, Gianquinto D, et al. Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol. 2002;28(4):418–23. PubMedCrossRef
26.
Zurück zum Zitat Rodriguez-Moranta F, Salo J, Arcusa A, et al. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol. 2006;24(3):386–93. PubMedCrossRef Rodriguez-Moranta F, Salo J, Arcusa A, et al. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol. 2006;24(3):386–93. PubMedCrossRef
27.
Zurück zum Zitat Pietra N, Sarli L, Costi R, Ouchemi C, Grattarola M, Peracchia A. Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized study. Dis Colon Rectum. 1998;41(9):1127–33. PubMedCrossRef Pietra N, Sarli L, Costi R, Ouchemi C, Grattarola M, Peracchia A. Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized study. Dis Colon Rectum. 1998;41(9):1127–33. PubMedCrossRef
28.
Zurück zum Zitat Ohlsson B, Breland U, Ekberg H, Graffner H, Tranberg KG. Follow-up after curative surgery for colorectal carcinoma: randomized comparison with no follow-up. Dis Colon Rectum. 1995;38(6):619–26. PubMedCrossRef Ohlsson B, Breland U, Ekberg H, Graffner H, Tranberg KG. Follow-up after curative surgery for colorectal carcinoma: randomized comparison with no follow-up. Dis Colon Rectum. 1995;38(6):619–26. PubMedCrossRef
29.
Zurück zum Zitat Kjeldsen BJ, Kronborg O, Fenger C, Jorgensen OD. A prospective randomized study of follow-up after radical surgery for colorectal cancer. Br J Surg. 1997;84(5):666–69. PubMedCrossRef Kjeldsen BJ, Kronborg O, Fenger C, Jorgensen OD. A prospective randomized study of follow-up after radical surgery for colorectal cancer. Br J Surg. 1997;84(5):666–69. PubMedCrossRef
30.
Zurück zum Zitat Makela JT, Laitinen SO, Kairaluoma MI. Five-year follow-up after radical surgery for colorectal cancer: results of a prospective randomized trial. Arch Surg. 1995;130(10):1062–7. PubMedCrossRef Makela JT, Laitinen SO, Kairaluoma MI. Five-year follow-up after radical surgery for colorectal cancer: results of a prospective randomized trial. Arch Surg. 1995;130(10):1062–7. PubMedCrossRef
31.
Zurück zum Zitat Renehan AG, Egger M, Saunders MP, O’Dwyer ST. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ. 2002;324(7341):813. PubMedCentralPubMedCrossRef Renehan AG, Egger M, Saunders MP, O’Dwyer ST. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ. 2002;324(7341):813. PubMedCentralPubMedCrossRef
32.
Zurück zum Zitat Jeffery M, Hickey BE, Hider PN. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev. 2007;(1):CD002200. Jeffery M, Hickey BE, Hider PN. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev. 2007;(1):CD002200.
33.
Zurück zum Zitat Primrose JN, Perera R, Gray A, Rose P, Fuller A, Corkhill A, George S, Mant D, FACS Trial Investigators. Effect of 3–5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. JAMA. 2014;311(3):263–70. doi:10.1001/jama.2013.285718. PubMed PMID: 24430319. Primrose JN, Perera R, Gray A, Rose P, Fuller A, Corkhill A, George S, Mant D, FACS Trial Investigators. Effect of 3–5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. JAMA. 2014;311(3):263–70. doi:10.1001/jama.2013.285718. PubMed PMID: 24430319.
34.
Zurück zum Zitat Verberne C, Doornbos PM, Grossmann I, De Bock GH, Wiggers T. Intensified follow-up in colorectal cancer patients using frequent carcino-embryonic antigen (CEA) measurements and CEA-triggered imaging. ESMO congress 2013; Abstr. 2151. Verberne C, Doornbos PM, Grossmann I, De Bock GH, Wiggers T. Intensified follow-up in colorectal cancer patients using frequent carcino-embryonic antigen (CEA) measurements and CEA-triggered imaging. ESMO congress 2013; Abstr. 2151.
35.
Zurück zum Zitat Bruinvels DJ, Stiggelbout AM, Kievit J, van Houwelingen HC, Habbema JD, van de Velde CJ. Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg. 1994;219(2):174–82. PubMedCentralPubMedCrossRef Bruinvels DJ, Stiggelbout AM, Kievit J, van Houwelingen HC, Habbema JD, van de Velde CJ. Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg. 1994;219(2):174–82. PubMedCentralPubMedCrossRef
36.
Zurück zum Zitat Moertel CG, Fleming TR, MacDonald JS, Haller DG, Laurie JA, Tangen C. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA. 1993;270(8):943–7. PubMedCrossRef Moertel CG, Fleming TR, MacDonald JS, Haller DG, Laurie JA, Tangen C. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA. 1993;270(8):943–7. PubMedCrossRef
37.
Zurück zum Zitat Safi F, Beyer HG. The value of follow-up after curative surgery of colorectal carcinoma. Cancer Detect Prev. 1993;17(3):417–24. PubMed Safi F, Beyer HG. The value of follow-up after curative surgery of colorectal carcinoma. Cancer Detect Prev. 1993;17(3):417–24. PubMed
38.
Zurück zum Zitat Zeng Z, Cohen AM, Urmacher C. Usefulness of carcinoembryonic antigen monitoring despite normal preoperative values in node-positive colon cancer patients. Dis Colon Rectum. 1993;36(11):1063–8. PubMedCrossRef Zeng Z, Cohen AM, Urmacher C. Usefulness of carcinoembryonic antigen monitoring despite normal preoperative values in node-positive colon cancer patients. Dis Colon Rectum. 1993;36(11):1063–8. PubMedCrossRef
39.
Zurück zum Zitat Cardoso R, Coburn NG, Seevaratnam R, et al. A systematic review of patient surveillance after curative gastrectomy for gastric cancer: a brief review. Gastric Cancer. 2012;15:19–26. CrossRef Cardoso R, Coburn NG, Seevaratnam R, et al. A systematic review of patient surveillance after curative gastrectomy for gastric cancer: a brief review. Gastric Cancer. 2012;15:19–26. CrossRef
40.
Zurück zum Zitat Stahl M, Mariette C, Haustermans K, et al. Oesophageal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up, Ann Oncol. 2013;24(Suppl. 6):51–6. Stahl M, Mariette C, Haustermans K, et al. Oesophageal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up, Ann Oncol. 2013;24(Suppl. 6):51–6.
41.
Zurück zum Zitat Waddell T, Verheij M, Allum W, et al. Gastric cancer: ESMO–ESSO–ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl. 6):57–63. Waddell T, Verheij M, Allum W, et al. Gastric cancer: ESMO–ESSO–ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl. 6):57–63.
42.
43.
Zurück zum Zitat Witkowski ER, Smith JK, Ragulin-Coyne E, et al. Is it worth looking? Abdominal imaging after pancreatic cancer resection: a national study. J Gastrointest Surg. 2012;16:121–8. PubMedCrossRef Witkowski ER, Smith JK, Ragulin-Coyne E, et al. Is it worth looking? Abdominal imaging after pancreatic cancer resection: a national study. J Gastrointest Surg. 2012;16:121–8. PubMedCrossRef
44.
Zurück zum Zitat Hishinuma S, Ogata Y, Tomikawa M, et al. Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg. 2006;10:511–8. PubMedCrossRef Hishinuma S, Ogata Y, Tomikawa M, et al. Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg. 2006;10:511–8. PubMedCrossRef
45.
Zurück zum Zitat Tzeng CW, Fleming JB, Lee JE, et al. Defined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapy. Ann Surg Oncol. 2012;19:2045–53. PubMedCrossRef Tzeng CW, Fleming JB, Lee JE, et al. Defined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapy. Ann Surg Oncol. 2012;19:2045–53. PubMedCrossRef
46.
Zurück zum Zitat Nordby T, Hugenschmidt H, Fagerland MW, et al. Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival. Eur J Surg. 2012;39:559–66. CrossRef Nordby T, Hugenschmidt H, Fagerland MW, et al. Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival. Eur J Surg. 2012;39:559–66. CrossRef
47.
Zurück zum Zitat Seufferlein T, Bachet JB, Van Cutsem E, et al. Üancreatic adenocarcinoma: ESMO–ESDO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;24(Suppl. 7):33–40. Seufferlein T, Bachet JB, Van Cutsem E, et al. Üancreatic adenocarcinoma: ESMO–ESDO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;24(Suppl. 7):33–40.
Metadaten
Titel
Follow-up in gastrointestinal cancer
verfasst von
Ulrich Popper
Clemens Dormann
MD Holger Rumpold
Publikationsdatum
01.05.2014
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 2/2014
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-014-0152-x